| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10212918 | The Annals of Thoracic Surgery | 2018 | 8 Pages |
Abstract
Patients unsuitable for TF TAVR treated with TC or TCav access had 30-day/in-hospital and 1-year survival similar to a contemporary cohort undergoing TF access. Avoiding surgical entry to the chest may offer procedural and intermediate-term outcomes equivalent to TF TAVR.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Gaetano MD, Marvin MD, Loay S. MD, Jamil MD, Ed PhD, Brianna MS, Benjamin PA-C, Dee Dee MD, William W. MD, Adam B. MD,